Fei Sun
Impact in
- Immunology top 10%
- Immune cells in cancer
- Immune Cell Function and Interaction
Papers in
-
- Ubiquitin and proteasome pathways 7
- Inflammasome and immune disorders 5
- Immunology 32
- Immune Cell Function and Interaction 12
- Immune cells in cancer 7
- Co-authors
- Faxi Wang (19 shared papers)Junyi Li (12 shared papers)Haifeng Zhou (14 shared papers)Cong‐Yi Wang (21 shared papers)Tiantian Yue (13 shared papers)Chunliang Yang (14 shared papers)Zushun Xu (4 shared papers)Heng Fan (6 shared papers)
- Journals
- Frontiers in Immunology (6 papers)Frontiers in Pharmacology (3 papers)Acta Pharmaceutica Sinica B (2 papers)Nature Communications (2 papers)Chemical Engineering Journal (2 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Fei Sun
92 papers receiving 1.4k citations
Hit Papers
Peers
Comparison fields: 5 of 134
- Immunology 286
- Biological Psychiatry 26
- Cancer Research 127
- Molecular Biology 572
- Pharmacology 56
Countries citing papers authored by Fei Sun
This map shows the geographic impact of Fei Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fei Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fei Sun more than expected).
Fields of papers citing papers by Fei Sun
This network shows the impact of papers produced by Fei Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fei Sun. The network helps show where Fei Sun may publish in the future.
Co-authors
The 25 scholars most cited alongside Fei Sun, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 101 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 80 | |
| 2 | 2014 | 64 | |
| 3 | 2021 | 54 | |
| 4 | 2018 | 53 | |
| 5 | 2022 | 52 | |
| 6 | 2018 | 51 | |
| 7 | 2020 | 50 | |
| 8 | 2022 | 49 | |
| 9 | 2022 | 49 | |
| 10 | 2019 | 48 | |
| 11 | 2017 | 47 | |
| 12 | 2017 | 35 | |
| 13 | 2020 | 33 | |
| 14 | 2018 | 31 | |
| 15 | 2020 | 31 | |
| 16 | 2020 | 31 | |
| 17 | 2023 | 30 | |
| 18 | 2021 | 30 | |
| 19 | HMGB1 exacerbates bronchiolitis obliterans syndrome via RAGE/NF-κB/HPSE signaling to enhance latent TGF-β release from ECM. | 2016 | 30 |
| 20 | 2023 | 29 |
About Fei Sun
Fei Sun is a scholar working on Molecular Biology, Immunology, Genetics, Surgery and Physiology, having authored 101 papers that have together received 1.4k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (12 papers), Diabetes and associated disorders (9 papers), Immune cells in cancer (7 papers), Ubiquitin and proteasome pathways (7 papers), Alzheimer's disease research and treatments (6 papers), Pancreatic function and diabetes (6 papers), Inflammatory Bowel Disease (5 papers) and Inflammasome and immune disorders (5 papers). The work is most often cited by research in Immunology (286 citations), Biological Psychiatry (26 citations), Cancer Research (127 citations), Molecular Biology (572 citations) and Pharmacology (56 citations). Fei Sun has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Faxi Wang, Junyi Li, Haifeng Zhou, Cong‐Yi Wang, Tiantian Yue, Chunliang Yang, Zushun Xu, Heng Fan, Fei Xiong and Jia‐Hui Luo. Their work appears in journals such as Frontiers in Immunology, Frontiers in Pharmacology, Acta Pharmaceutica Sinica B, Nature Communications and Chemical Engineering Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.